Curran, Valerie

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,540

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update

Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 236

Identification of a narrow post-ovulatory window of vulnerability to distressing involuntary memories in healthy women

Soni, M., Curran, V. H., & Kamboj, S. K. (2013) · Neurobiology of Learning and Memory

Posttraumatic Stress Disorder ResearchMemory Processes and Influences

Cited by 102

Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis

Gunasekera, B., Davies, C., Blest-Hopley, G., Veronese, M., Ramsey, N. F., Bossong, M. G., Radua, J., Bhattacharyya, S., Pretzsch, C., McAlonan, G., et al. (2022) · Neuroscience & Biobehavioral Reviews

Cannabis and Cannabinoid ResearchPsychedelics and Drug Studies

Cited by 10